Пошуковий запит: (<.>U=Р562.9$<.>) |
Загальна кількість знайдених документів : 167
Представлено документи з 1 до 20
|
| | |
| 1. |
Копильчук Г. П. 5'-нуклеотидазна й АМФ-дезаміназна активності постнуклеарної фракції печінки та сироватки крові щурів із трансплантованою карциномою Герена // Біол. студії. - 2009. - 3, № 3.
|
| 2. |
Kopylchuk H. P. A possible mechanism of antitumor activity of 5-(5',6'-benzocoumaroyl-3')-methylaminouracil in vivo. — 2007 // Эксперим. онкология.
|
| 3. |
Naleskina L. A. Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin // Эксперим. онкология. - 2013. - 35, № 3.
|
| 4. |
Pyaskovskaya O. N. Analysis of growth kinetics and proliferative heterogeneity of Lewis lung carcinoma cells growing as unfed culture. — 2008 // Онкология.
|
| 5. |
Symchych T. V. Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma // Эксперим. онкология. - 2017. - 39, № 1.
|
| 6. |
Smirnova L. P. Antioxidant enzyme activities in the cells of solid and ascitic Ehrlich carcinomas. — 2003 // Эксперим. онкология.
|
| 7. |
Gambashidze K. Antitumor and adjuvant effects of phagelysates of E. coli in mice with Ehrlich carcinoma // Эксперим. онкология. - 2012. - 34, № 2.
|
| 8. |
Didenko G. V. Antitumor and antimetastatic efficiency of antitumor vaccine and amixin combined action in mice with Lewis lung carcinoma // Biotechnologia Acta. - 2016. - 9, № 3.
|
| 9. |
Shlyakhovenko V. Application of DNA from mushroom Pleurotus ostreatus for cancer biotherapy: a pilot studу. — 2006 // Эксперим. онкология.
|
| 10. |
Goltsev A. N. Application of nanoparticles based on rare earth orthovanadates to inactivate Ehrlich carcinoma growth // Biotechnologia Acta. - 2015. - 8, № 4.
|
| 11. |
Bubnovskaya L. Bioenergetic status and hypoxia in Lewis lung carcinoma assessed by <$E bold {~sup 31 roman P}> NMR spectroscopy: correlation with tumor progression. — 2007 // Эксперим. онкология.
|
| 12. |
Marais R. BRAF and RAS signaling in human melanoma // Укр. біохім. журн.. - 2009. - 81, № 4 (спец. вип.).
|
| 13. |
Pyaskovskaya O. N. Changes in VEGF level and tumor growth characteristics during Lewis lung carcinoma progression towards cis-DDP resistance. — 2007 // Эксперим. онкология.
|
| 14. |
Areshkov P. A. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells. — 2010 // Цитология и генетика.
|
| 15. |
Dasyukevich O. I. Comparative study of anticancer efficacy of aconitine-containing agent BC1 against ascite and solid forms of Ehrlich's carcinoma. — 2007 // Эксперим. онкология.
|
| 16. |
Raetska Y. Correction of oxidant-antioxidant system in rats with Geren carcinoma in radiotherapy // Укр. біохім. журн.. - 2009. - 81, № 4 (спец. вип.).
|
| 17. |
Yakshibaeva Yu. R. Decrease in migration capacity of Lewis lung carcinoma cells during tumor growth and metastasis. — 2002 // Эксперим. онкология.
|
| 18. |
Amikishieva A. V. Depressive-like psychoemotional state versus acute stresses enhances Lewis lung carcinoma metastasis in C57BL/6J mice // Эксперим. онкология. - 2011. - 33, № 4.
|
| 19. |
Bubnovskaya L. N. Detection of tumor response to Co(III) and Fe(III) complexes by <$E bold {nothing sup 31 roman P}>-nuclear magnetic resonance spectroscopy. — 2002 // Эксперим. онкология.
|
| 20. |
Pyaskovskaya O. N. Dynamics of changes of antioxidant system indexes during the growth of two Lewis lung carcinoma variants // Эксперим. онкология. - 2014. - 36, № 1.
|
| | |
НОВІ
ПОШУК
Книжкові видання та компакт-диски
